: Prophylactic effect of vitamin D supplementation in the prevention of atrial fibrillation after coronary artery bypass grafting : Randomized Clinical Trial

Phase 2

Recruiting

• Conditions: Condition 1: Atrial fibrillation after CABG. Condition 2: Atrial fibrillation after CABG.; Paroxysmal atrial fibrillation; Unspecified complication of cardiac and vascular prosthetic device, implant and graft; I48.0; T82.9

• Registration Number: IRCT20201028049175N4
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Patients who are condidated for elective CABG that have informed consent for joining to the study.
All patients that duration of their surgery is less than 6 hours.
Serum level of vit D less than 30 nanomol per litr

Exclusion Criteria

History of having arrhythmia and atrial fibrillation
History of using antiarrhythmic drugs in class I and III or Digoxin
History of having permanent or temporary heart pace maker
History of atrioventricular block or bradycardia with less than 50 heart beat per minute
History of severe kidney or pulmonary (pneumonia or chronic obstractive pulmonary disease ) or liver (cirrhosis or fulminant hepatitis) disease
Non elective CABG
Patients who need heart valve replacement surgery, in addition to CABG

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Frequency of post CABG atrial fibrillation. Timepoint: From the end of surgery untill 72 hours after surgery. Method of measurement: heart monitoring.